<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29763458</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Immunity levels to poliovirus in Lao children and adults before the vaccine-derived poliovirus outbreak: A retrospective study.</ArticleTitle><Pagination><StartPage>e0197370</StartPage><MedlinePgn>e0197370</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0197370</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0197370</ELocationID><Abstract><AbstractText>In 2015, several provinces in Lao People's Democratic Republic (Lao PDR) experienced a vaccine-derived poliovirus outbreak. This survey was conducted (i) to evaluate the vaccination coverage in different settings and cohorts using the seroprevalence of anti-poliovirus (PV) antibodies as a surrogate measure, and (ii) to explore the usefulness of an ELISA in a country with limited resources and a specific epidemiological setting. IgG antibodies were assessed by ELISA in Lao children (n = 1216) and adults (n = 1228), including blood donors and health care workers. Protective antibody titers against the 3 vaccine serotypes were determined by microneutralization (VNT) in a subset of participants. More than 92% of the children had anti-poliovirus antibodies, regardless of nutritional status or access to health care, highlighting the success of the vaccination outreach activities in the country. In contrast, anti-poliovirus seroprevalence reached only 81.7% in blood donors and 71.9% in health care workers. Participants born before the introduction of poliovirus vaccination in Lao PDR were considerably less likely to be seropositive. These findings align with the epidemiology of the outbreak. Neutralizing antibodies against at least one of the 3 poliovirus serotypes were detected in all children (99/99) and 93/99 had antibodies against all serotypes. Similarly, all health care workers had neutralizing antibodies against at least one and 92/99 against all serotypes. The comparison of both assays shows an acceptable underestimation of vaccine coverage in children by ELISA, but a low sensitivity of the ELISA in the adults. We show that the ELISA is a reasonable alternative to the VNT in particular in vaccinated children, that an improved version should be serotype specific, and that negativity thresholds should be revisited for optimal sensitivity and specificity. Thus, polio-free countries with an uncertain vaccination coverage and limited laboratory capacity, that are at risk of vaccine-derived poliovirus outbreaks or of re-importation of wild poliovirus may benefit from an improved ELISA for cohort studies to evaluate their immunization program in children.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pauly</LastName><ForeName>Maude</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6428-3140</Identifier><AffiliationInfo><Affiliation>Infectious Diseases Research Unit, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Antony P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Lao-Lux-Laboratory, Institute Pasteur du Laos, Vientiane, Lao People's Democratic Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khampanisong</LastName><ForeName>Phonepaseuth</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Lao-Lux-Laboratory, Institute Pasteur du Laos, Vientiane, Lao People's Democratic Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nouanthong</LastName><ForeName>Phonethipsavanh</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Lao-Lux-Laboratory, Institute Pasteur du Laos, Vientiane, Lao People's Democratic Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xfc;bschen</LastName><ForeName>Judith M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Infectious Diseases Research Unit, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nanthavong</LastName><ForeName>Naphavanh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institut de la Francophonie pour la Medecine Tropicale, Vientiane, Lao People's Democratic Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sayasinh</LastName><ForeName>Kong</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institut de la Francophonie pour la Medecine Tropicale, Vientiane, Lao People's Democratic Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jutavijittum</LastName><ForeName>Prapan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samountry</LastName><ForeName>Bounthome</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Faculty of Basic Sciences, University of Health Sciences, Vientiane, Lao People's Democratic Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xeuatvongsa</LastName><ForeName>Anonh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Immunization Programme, Lao Ministry of Health, Vientiane, Lao People's Democratic Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diedrich</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muller</LastName><ForeName>Claude P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Infectious Diseases Research Unit, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lao-Lux-Laboratory, Institute Pasteur du Laos, Vientiane, Lao People's Democratic Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire National de Sant&#xe9;, Dudelange, Luxembourg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D023321">Poliovirus Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007812" MajorTopicYN="N">Laos</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="N">Poliomyelitis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023321" MajorTopicYN="N">Poliovirus Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>5</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29763458</ArticleId><ArticleId IdType="pmc">PMC5953481</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0197370</ArticleId><ArticleId IdType="pii">PONE-D-17-26749</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Morales M, Tangermann RH, Wassilak SG. Progress Toward Polio Eradication&#x2014;Worldwide, 2015&#x2013;2016. MMWR Morb Mortal Wkly Rep. 2016;65(18):470&#x2013;3. Epub 2016/05/14. doi: 10.15585/mmwr.mm6518a4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6518a4</ArticleId><ArticleId IdType="pubmed">27171208</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Fifty years: working for health in the Lao People&#x2019;s Democratic Republic, 1962&#x2013;2012. 2013.</Citation></Reference><Reference><Citation>World Health Organization. Certification of poliomyelitis eradication. WHO Western Pacific Region, October 2000. Releve epidemiologique hebdomadaire. 2000;75(49):399&#x2013;400. Epub 2001/02/24. .</Citation><ArticleIdList><ArticleId IdType="pubmed">11189701</ArticleId></ArticleIdList></Reference><Reference><Citation>Tangermann RH, Bilous J, Maher C, Aylward RB, Schnur A, Sato Y, et al. Poliomyelitis eradication in the Western Pacific Region. The Journal of infectious diseases. 1997;175 Suppl 1:S97&#x2013;104. Epub 1997/02/01. .</Citation><ArticleIdList><ArticleId IdType="pubmed">9203700</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt LR, Estivariz CF, Sutter RW. Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden. The Journal of infectious diseases. 2014;210
Suppl 1:S380&#x2013;9. Epub 2014/10/16. doi: 10.1093/infdis/jiu184 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu184</ArticleId><ArticleId IdType="pmc">PMC10424844</ArticleId><ArticleId IdType="pubmed">25316859</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. The Journal of infectious diseases. 2014;210
Suppl 1:S283&#x2013;93. Epub 2014/10/16. doi: 10.1093/infdis/jiu295 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu295</ArticleId><ArticleId IdType="pubmed">25316847</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales M, Tangermann RH, W SG. Progress Toward Polio Eradication&#x2014;Worldwide, 2015&#x2013;2016. MMWR Morb Mortal Wkly Rep. 2016;65(18):470&#x2013;3. doi: 10.15585/mmwr.mm6518a4
</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6518a4</ArticleId><ArticleId IdType="pubmed">27171208</ArticleId></ArticleIdList></Reference><Reference><Citation>Prime Minister of Lao PDR Thongsing Thammavong. Declaration of a public health emergency in Lao PDR. https://www.dfa.ie/media/dfa/travel/PM-Lao-PDR-Declaration-National-Public-Health-Emergency-Jan-2016.pdf; 2016.</Citation></Reference><Reference><Citation>World Health Organization. Polio vaccines: WHO position paper, March 2016-recommendations. Vaccine. 2016.  Epub 2016/11/30. doi: 10.1016/j.vaccine.2016.11.017 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.11.017</ArticleId><ArticleId IdType="pubmed">27894720</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Polio eradication endgame (2013&#x2013;2018). 2013.</Citation></Reference><Reference><Citation>World Health Organization. Introduction to inactivated polio vaccine and switch from trivalent to bivalent oral poliovirus vaccine worldwide, 2013&#x2013;2016. Releve epidemiologique hebdomadaire. 2015;90(27):337&#x2013;43. Epub 2015/07/15. .</Citation><ArticleIdList><ArticleId IdType="pubmed">26151981</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Regional Office for the Western Pacific. Polio Bulletin&#x2014;2017, Issue no. 2 (Week 3). 2017.</Citation></Reference><Reference><Citation>World Health Organization. Polio laboratory manual. Geneva, Switzerland: 2004.</Citation></Reference><Reference><Citation>Evdokimov K, Sayasinh K, Nouanthong P, Vilivong K, Samountry B, Phonekeo D, et al.
Low and disparate seroprotection after pentavalent childhood vaccination in the Lao People's Democratic Republic: a cross-sectional study. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2016.  Epub 2016/10/21. doi: 10.1016/j.cmi.2016.10.007 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2016.10.007</ArticleId><ArticleId IdType="pubmed">27756713</ArticleId></ArticleIdList></Reference><Reference><Citation>Venables WNaR, D. B. Modern Applied Statistics with S. Fourth ed. New York: Springer; 2002.</Citation></Reference><Reference><Citation>Wickham H. ggplot2: Elegant Graphics for Data Analysis: Springer-Verlag; New York; 2009.</Citation></Reference><Reference><Citation>Fox J. and Weisberg S. An {R} Companion to Applied Regression. Second Edition ed. Thousans Oaks {CA}: Sage Publications; 2011.</Citation></Reference><Reference><Citation>Eddelbuettel DaF, R. Rcpp: Seamless R and C++ Integration. Journal of Statistical Software. 2011;40(8):1&#x2013;18.</Citation></Reference><Reference><Citation>Kuroiwa C, Vongphrachanh P, Chosa T, Murakami H, Hashizume M, Wakai S, et al.
Risk of poliomyelitis importation and re-emergence in Laos. Lancet. 2000;356(9240):1487&#x2013;8. Epub 2000/11/18. doi: 10.1016/S0140-6736(00)02874-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)02874-9</ArticleId><ArticleId IdType="pubmed">11081534</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Polio Regional Strategic Plan 2008&#x2013;2012. 2008.</Citation></Reference><Reference><Citation>Adams A, Boualam L, Diorditsa S, Gregory C, Jee Y, Mendoza-Aldana J, et al.
Maintaining polio-free certification in the World Health Organization Western Pacific Region for over a decade. The Journal of infectious diseases. 2014;210
Suppl 1:S259&#x2013;67. Epub 2014/10/16. doi: 10.1093/infdis/jiu164 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu164</ArticleId><ArticleId IdType="pmc">PMC10424813</ArticleId><ArticleId IdType="pubmed">25316844</ArticleId></ArticleIdList></Reference><Reference><Citation>UNICEF, WHO. WHO-UNICEF estimates of Pol3 coverage 2015.</Citation></Reference><Reference><Citation>Saleem AF, Mach O, Quadri F, Khan A, Bhatti Z, Rehman NU, et al.
Immunogenicity of poliovirus vaccines in chronically malnourished infants: a randomized controlled trial in Pakistan. Vaccine. 2015;33(24):2757&#x2013;63. Epub 2015/04/29. doi: 10.1016/j.vaccine.2015.04.055 ; PubMed Central PMCID: PMCPmc4447616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.04.055</ArticleId><ArticleId IdType="pmc">PMC4447616</ArticleId><ArticleId IdType="pubmed">25917673</ArticleId></ArticleIdList></Reference><Reference><Citation>Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis. 1991;13(5):926&#x2013;39. Epub 1991/09/01. .</Citation><ArticleIdList><ArticleId IdType="pubmed">1660184</ArticleId></ArticleIdList></Reference><Reference><Citation>Chand T, Sahu AK, Saha K, Singh V, Meena J, Singh S. Stability of oral polio vaccine at different temperatures and its correlation with vaccine vial monitors. Current science. 2008;94(2):172&#x2013;5.</Citation></Reference><Reference><Citation>world Health Organization. Guidelines on stability evaluation of vaccines. 2011.</Citation></Reference><Reference><Citation>Abbink F, Buisman AM, Doornbos G, Woldman J, Kimman TG, Conyn-van Spaendonck MA. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion. The Journal of infectious diseases. 2005;191(6):990&#x2013;9. Epub 2005/02/18. doi: 10.1086/427810 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/427810</ArticleId><ArticleId IdType="pubmed">15717277</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, Duintjer Tebbens RJ, Thompson KM. The probability of undetected wild poliovirus circulation after apparent global interruption of transmission. Am J Epidemiol. 2012;175(9):936&#x2013;49. Epub 2012/03/31. doi: 10.1093/aje/kwr399 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwr399</ArticleId><ArticleId IdType="pubmed">22459121</ArticleId></ArticleIdList></Reference><Reference><Citation>Hird TR, Grassly NC. Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus Challenge. PLoS Pathog. 2012;8(4). doi: 10.1371/journal.ppat.1002599 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002599</ArticleId><ArticleId IdType="pmc">PMC3330118</ArticleId><ArticleId IdType="pubmed">22532797</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>